XML 60 R38.htm IDEA: XBRL DOCUMENT v3.21.2
Net Income (Loss) Per Share (Tables)
12 Months Ended
Jun. 30, 2021
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table sets forth the computation of net income (loss) per share for the periods presented:

Year Ended June 30,
(in thousands, except per share amounts)
202120202019
Basic:
Numerator:
Net income$131,046 $81,147 $72,579 
Less: dividends declared on Series A, B, C & D preferred stock— (86,302)(661)
Less: cumulative dividends on Series D preferred stock— (10,849)(12,000)
Net income (loss) attributable to common shareholders131,046 (16,004)59,918 
Denominator:
Weighted-average common stock outstanding162,889 97,496 85,378 
Net income (loss) per share—basic:$0.80 $(0.16)$0.70 
Diluted:
Numerator:
Net income (loss) attributable to common shareholders$131,046 $(16,004)$59,918 
Add: dividends declared on Series A, B & C preferred stock(1)
— — 181 
Add: dividends declared on Series D preferred stock(1)
— — 480 
Add: cumulative dividends on Series D preferred stock(1)
— — 12,000 
Net income (loss) attributable to common and common equivalent shareholders131,046 (16,004)72,579 
Denominator:
Weighted-average common stock outstanding162,889 97,496 85,378 
Series A, B & C preferred stock outstanding(1)
— — 12,071 
Series D preferred stock outstanding(1)
— — 32,000 
Stock options outstanding to purchase shares of common stock including unvested RSU's and from the ESPP(1)
2,655 — 3,042 
Total common and common equivalent shares outstanding165,544 97,496 132,491 
Net income (loss) per share—diluted:$0.79 $(0.16)$0.55 
(1) Excluded from the computation of net loss per share-diluted for the year ended June 30, 2020, because the effect would have been anti-dilutive.
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The weighted average potential shares of common stock that were excluded from the calculation of net income (loss) per share-diluted for the periods presented because including them would have been anti-dilutive consisted of the following as of June 30:

(in thousands)202120202019
Series A, B & C preferred stock outstanding— 10,871 — 
Series D preferred stock outstanding— 28,817 — 
Series E preferred stock outstanding— 694 — 
Stock options outstanding to purchase shares of common stock including unvested RSU's and from the ESPP784 4,161 — 
Shares subject to outstanding PSU's(1)
121 — — 
Total905 44,543 — 
(1) The weighted-average number of shares excluded from the computation of net income (loss) per share-diluted because the performance conditions associated with these awards were not met.